Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

Dupixent is the first new targeted therapy to receive FDA-approval for chronic spontaneous urticaria in adults and ...

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.